** Shares of contract research firm Syngene International
SYNN.NS fall ~2% to 701.75 rupees
** Stock fell 2.3% on Tuesday after UBS downgraded rating to
"sell" from "buy" and cut PT to 700 rupees from 875 rupees
** UBS' new PT lowest among seven analysts on SYNN, per LSEG
** Stock shed 4.4% in last two sessions
** Weak demand for the discovery and dedicated segments to
put pressure on Syngene's near-term revenue growth - UBS
** Adds, concerns are rising with slow ramp-up of SYNN's API
unit
** Avg rating of analysts at "hold"; median PT is 750 rupees
- LSEG data
** Stock rose 20% in 2023, snapping two consecutive years of
decline
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))